Literature DB >> 2391358

Detoxifying enzymes in human ovarian tissues: comparison of normal and tumor tissues and effects of chemotherapy.

Z Djuric1, V K Malviya, G Deppe, J M Malone, D L McGunagle, L K Heilbrun, B A Reading, W D Lawrence.   

Abstract

Many anticancer drugs exert their cytotoxic effects via formation of oxygen free radicals. Cellular thiols, glutathione (GSH)-dependent enzymes and other redox enzymes are involved in the metabolism of these anticancer drugs and of the oxygen free radicals that may be generated during their metabolism. We quantified these biochemical parameters in cytosol from human ovarian tissues. We compared non-protein thiol levels, GSH transferase, GSH peroxidase, superoxide dismutase, catalase, DT diaphorase and aldehyde dehydrogenase activity in serous ovarian tumors (n = 15), other malignant ovarian tumors (n = 12), benign ovarian tissue (n = 10) and histologically normal ovarian tissue (n = 12). Mean GSH transferase and DT diaphorase activities were similar in serous and other malignant ovarian tumors. GSH transferase activity was decreased in malignant tissues relative to normal and benign tissues. Mean DT diaphorase and superoxide dismutase activities were increased in the malignant tissues, although this was not statistically significant. The mean levels of all enzymes except superoxide dismutase and aldehyde dehydrogenase in benign tissues were fairly similar to the mean levels found in normal tissue samples. Tissues from patients with serous ovarian tumors, who had received cyclophosphamide and cisplatin prior to surgery, also were analyzed (n = 7). Except for aldehyde dehydrogenase, all the parameters measured were decreased in these samples relative to serous tissue from untreated patients. These biochemical analyses may be useful in understanding the mechanisms involved in the response to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391358     DOI: 10.1007/bf01612921

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  21 in total

1.  High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives.

Authors:  M W Fariss; D J Reed
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  Role of the glutathione redox cycle in acquired and de novo multidrug resistance.

Authors:  R A Kramer; J Zakher; G Kim
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

3.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion.

Authors:  P A Andrews; M A Schiefer; M P Murphy; S B Howell
Journal:  Chem Biol Interact       Date:  1988       Impact factor: 5.192

5.  DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation.

Authors:  C Lind; P Hochstein; L Ernster
Journal:  Arch Biochem Biophys       Date:  1982-06       Impact factor: 4.013

6.  Superoxide dismutase assays.

Authors:  L Flohé; F Otting
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

Review 7.  Charge transfer-oxy radical mechanism for anti-cancer agents.

Authors:  P Kovacic; J R Ames; P Lumme; H Elo; O Cox; H Jackson; L A Rivera; L Ramirez; M D Ryan
Journal:  Anticancer Drug Des       Date:  1986-11

8.  Implications for therapy of drug-metabolizing enzymes in human colon cancer.

Authors:  K Mekhail-Ishak; N Hudson; M S Tsao; G Batist
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

9.  Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung.

Authors:  J Carmichael; L M Forrester; A D Lewis; J D Hayes; P C Hayes; C R Wolf
Journal:  Carcinogenesis       Date:  1988-09       Impact factor: 4.944

10.  Glutathione localisation in benign and malignant human breast lesions.

Authors:  G I Murray; M D Burke; S W Ewen
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

View more
  4 in total

1.  Degradable redox-responsive disulfide-based nanogel drug carriers via dithiol oxidation polymerization.

Authors:  Sussana A Elkassih; Petra Kos; Hu Xiong; Daniel J Siegwart
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

Review 2.  Glutathione levels in human tumors.

Authors:  Michael P Gamcsik; Mohit S Kasibhatla; Stephanie D Teeter; O Michael Colvin
Journal:  Biomarkers       Date:  2012-08-20       Impact factor: 2.658

3.  Detoxification ability and toxicity of quinones in mouse and human tumor cell lines used for anticancer drug screening.

Authors:  Z Djuric; T H Corbett; F A Valeriote; L K Heilbrun; L H Baker
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.

Authors:  A G van der Zee; B van Ommen; C Meijer; H Hollema; P J van Bladeren; E G de Vries
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.